DR. YOGYA REDDY

DR. SYED FARAAZ HUSSAIN, DR. ANAMIKA PANDEY, DR. AYUSHI OJHA

Abstract

Ocular myasthenia gravis (OMG) is a subtype of the systemic disease which affects only the eye but many patients do progress to generalized form. The mainstay of treatment are acetyl choline esterase inhibitors along with corticosteroids and/or immunosuppressant drugs which is aimed at disease remission and prevention of progression to the generlized form. We report a case of a 9 year old female patient who was diagnosed as OMG. She was on oral steroids, unmonitored from the past 4 years and came to us for persistent variability of symptoms and was found to have disc changes suspicious of glaucoma with IOP on higher side in both eyes along variable ptosis and diplopia. Systemically she had mild stunting of growth for which we involved a team of paediatrician and endocrinologist who advised tapering and regular monitoring. We hope to stress upon the importance of ophthalmic and systemic monitoring of patients on steroids for ophthalmologic conditions, specially the paediatric age group.